全文获取类型
收费全文 | 110412篇 |
免费 | 8830篇 |
国内免费 | 5052篇 |
专业分类
耳鼻咽喉 | 604篇 |
儿科学 | 1835篇 |
妇产科学 | 1381篇 |
基础医学 | 19128篇 |
口腔科学 | 2319篇 |
临床医学 | 8474篇 |
内科学 | 17531篇 |
皮肤病学 | 1704篇 |
神经病学 | 8958篇 |
特种医学 | 1802篇 |
外国民族医学 | 25篇 |
外科学 | 6674篇 |
综合类 | 18231篇 |
现状与发展 | 27篇 |
预防医学 | 5851篇 |
眼科学 | 1203篇 |
药学 | 13288篇 |
15篇 | |
中国医学 | 3313篇 |
肿瘤学 | 11931篇 |
出版年
2024年 | 174篇 |
2023年 | 1266篇 |
2022年 | 2375篇 |
2021年 | 4105篇 |
2020年 | 3318篇 |
2019年 | 2852篇 |
2018年 | 2724篇 |
2017年 | 3115篇 |
2016年 | 3458篇 |
2015年 | 4096篇 |
2014年 | 6572篇 |
2013年 | 7206篇 |
2012年 | 6742篇 |
2011年 | 7809篇 |
2010年 | 6277篇 |
2009年 | 6242篇 |
2008年 | 6404篇 |
2007年 | 6275篇 |
2006年 | 5667篇 |
2005年 | 5244篇 |
2004年 | 4488篇 |
2003年 | 3986篇 |
2002年 | 3176篇 |
2001年 | 2756篇 |
2000年 | 2451篇 |
1999年 | 2086篇 |
1998年 | 1830篇 |
1997年 | 1621篇 |
1996年 | 1362篇 |
1995年 | 1115篇 |
1994年 | 951篇 |
1993年 | 774篇 |
1992年 | 645篇 |
1991年 | 573篇 |
1990年 | 465篇 |
1989年 | 387篇 |
1988年 | 374篇 |
1987年 | 342篇 |
1986年 | 309篇 |
1985年 | 444篇 |
1984年 | 413篇 |
1983年 | 253篇 |
1982年 | 321篇 |
1981年 | 253篇 |
1980年 | 226篇 |
1979年 | 152篇 |
1978年 | 137篇 |
1977年 | 115篇 |
1976年 | 99篇 |
1975年 | 80篇 |
排序方式: 共有10000条查询结果,搜索用时 165 毫秒
11.
周蕾 《国际妇产科学杂志》2015,42(1):91-95
宫颈癌对妇女健康构成严重威胁,人乳头瘤病毒感染与宫颈病变及宫颈癌的发生密切相关。关于宫颈癌发生发展的机制仍在研究中。近年研究发现一种多功能核蛋白,即死亡结构域相关蛋白(death domain associated protein,Daxx),其与细胞内蛋白或病毒蛋白相互作用,参与调节细胞凋亡、转录调控、抗病毒等细胞活动,在不同途径中发挥不同的生理或病理作用。通过对Daxx功能及其作用机制的研究有助于进一步阐明宫颈癌发生发展的机制,有助于发现新的预防和治疗方法。综述Daxx的一般特性和研究现况及其在宫颈病变的研究进展。 相似文献
12.
《Vaccine》2016,34(39):4724-4731
Human papillomavirus (HPV) infection is the most common sexually transmitted disease worldwide. HPVs are oncogenic small double-stranded DNA viruses that are the primary causal agent of cervical cancer and other types of cancers, including in the anus, oropharynx, vagina, vulva, and penis. Prophylactic vaccination against HPV is an attractive strategy for preventing cervical cancer and some other types of cancers. However, there are few safe and effective vaccines against HPV infections. Current first-generation commercial HPV vaccines are expensive to produce and deliver.The goal of this study was to develop an alternate potent HPV recombinant L1-based vaccines by producing HPV virus-like particles into a vaccine that is currently used worldwide. Live attenuated measles virus (MV) vaccines have a well-established safety and efficacy record, and recombinant MV (rMV) produced by reverse genetics may be useful for generating candidate HPV vaccines to meet the needs of the developing world.We studied in non-human primate rMV-vectored HPV vaccine in parallel with a classical alum adjuvant recombinant HPV16L1 and 18L1 protein vaccine produced in Pichia pastoris. A combined prime-boost approach using both vaccines was evaluated, as well as immune interference due to pre-existing immunity against the MV.The humoral immune response induced by the MV, Pichia-expressed vaccine, and their combination as priming and boosting approaches was found to elicit HPV16L1 and 18L1 specific total IgG and neutralizing antibody titres. Pre-existing antibodies against measles did not prevent the immune response against HPV16L1 and 18L1. 相似文献
13.
Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features
下载免费PDF全文
![点击此处可从《Histopathology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
14.
15.
16.
17.
18.
19.
《Mayo Clinic proceedings. Mayo Clinic》2019,94(7):1321-1329
Immune checkpoint inhibitors are molecules that increase the endogenous immune response against tumors. They have revolutionized the field of oncology. Since their initial approval for the treatment of advanced melanoma, their use has expanded to the treatment of several other advanced cancers. Unfortunately, immune checkpoint inhibitors have also been associated with the emergence of a new subset of autoimmune-like toxicities, known as immune-related adverse events. These toxicities differ depending on the agent, malignancy, and individual susceptibilities. Although the skin and colon are most commonly involved, any organ may be affected, including the liver, lungs, kidneys, and heart. Most of these toxicities are diagnosed by excluding other secondary infectious or inflammatory causes. Corticosteroids are commonly used for treatment of moderate and severe immune-related adverse events, although additional immunosuppressive therapy may occasionally be required. The occurrence of immune-related toxicities may require discontinuation of immunotherapy, depending on the specific toxicity and its severity. In this article, we provide a focused review to familiarize practicing clinicians with this important topic given that the use of immune checkpoint inhibitors continues to increase. 相似文献